System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Valérie Cormier-Daire is an expert in Genetics at Hôpital Necker-Enfants Malades (France). As of October 2026, ScienceLeadR ranks Valérie Cormier-Daire in the top 1% of experts worldwide for Dwarfism and Congenital Abnormalities. Valérie Cormier-Daire has authored 684 publications, the most recent in 2026, and is an investigator in 15 clinical trials, 5 of them ongoing. SLR score: 1,963 (community average: 125). How the SLR is computed.

LeadR Profile

Valérie Cormier-Daire Hôpital Necker-Enfants Malades France
1 963 ScienceLeadR Reputation 1963

Unlock

Register Login
Network Map

Genetics

Subspecialties: Biochemistry - Rheumatology - Pediatrics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1990 - 2026
Source: PubMed

Hôpital Necker-Enfants Malades

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 684

Citations

Citations: 29 529 1st author: 28 Last author: 228 Unique author: 3

Main journals

CRC Press eBooks 104
Am J Med Genet A 57
Eur J Hum Genet 46
Am J Hum Genet 44
J Med Genet 41

Best Journals

N Engl J Med 3
Nat Rev Endocrinol 3
Nature 3

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Deep intronic NIPBL variants underlie unresolved Cornelia de Lange syndrome revealed by integrated epigenomic and transcriptomic analysis.
PMID 42897219 — blood, epigenomics, de lange syndrome		Eur J Hum Genet20260
A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia.
PMID 42713641 — growth, therapeutics, child		NEJM Evid20260
The socioeconomic impacts of fibrodysplasia ossificans progressiva: evidence from a retrospective case-control study in France.
PMID 42713489 — comorbidity, mortality, case-control studies, prevalence, health personnel, snds		JBMR Plus20260
A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of vosoritide in children with hypochondroplasia: CANOPY HCH-3 study design.
PMID 42694461 — growth, safety, receptor, fibroblast growth factor, type 3, therapeutics, child		Ther Adv Endocrinol Metab20261
Myhre Syndrome: New Horizons in Clinical Care, Research and the Pursuit of Therapy.
PMID 42675991 — research, therapeutics		Am J Med Genet C Semin Med Genet20260

Clinical Studies 15

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 6
Phase 3 6
Phase 2 2
Phase 2/Phase 3 1

By status:

Completed 10
Recruiting 4
Active not recruiting 1

By type:

Interventional 10
Observational 5

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 1
multicentric5to9 1
multicentricup10 9

Main Topics

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Long Term Extension Study of Vosoritide to Treat Children with Hypochondroplasia
2024-517238-16-00 — safety, child		Phase 3Recruiting2026
Open Label followed by a Double Blind Placebo Controlled Study to Investigate the Efficacy and Safety of Infigratinib in Children with Hypochondroplasia
2024-516822-67-00 — safety, child		Phase 2/Phase 3Recruiting2025
Interventional Study of Vosoritide for the Treatment of Children With Hypochondroplasia
NCT06455059 — injections, osteochondrodysplasias, safety, dwarfism, pharmaceutical preparations, bone diseases, bone diseases, developmental, physiological effects of drugs, musculoskeletal diseases, natriuretic peptide, c-type, natriuretic peptides, therapeutics, natriuretic agents, injections, subcutaneous, genetic diseases, inborn, child		Phase 3Active not recruiting2024
A Natural History Study in Children With a Type II Collagen Disorder With Short Stature
NCT05408715 — natural history, dwarfism, collagen, bone diseases, biomarkers, signs and symptoms, history, child, collagen type ii		N/ARecruiting2022
Audio vestibular Evaluation of Children and Young Adults With Osteogenesis Imperfecta
NCT05419960 — eye, injections, research design, contrast media, tomography, osteogenesis, peripheral nervous system, magnetic resonance imaging, ear, hearing, audiometry, audiometry, speech, vestibular evoked myogenic potentials, eye movements, head impulse test, hearing loss, nervous system, deafness, movement, osteogenesis imperfecta, speech, child		N/ARecruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS